Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-11 of 11 for your search:
Cancer Type/Condition:
Brain tumor, child: General & other
Stage/Subtype:
childhood ependymoma, newly diagnosed
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Combination Chemotherapy With or Without Etoposide Followed By an Autologous Stem Cell Transplant in Treating Young Patients With Previously Untreated Malignant Brain Tumors
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Under 10 at diagnosis
Sponsor:
Other
Protocol IDs:
CHLA-HEAD-START-III
, CHLA-HSIII, CHLA-2004-020, CHLA-04.020, NCT00392886, UMN-MT2004-06
2.
A Study for Image-Guided Radiation Therapy in Pediatric Brain Tumors and Side Effects
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
8 months to 25 years
Sponsor:
Other
Protocol IDs:
RT1
, NCT00187226
3.
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
MSKCC-05122
, NCT00445965
4.
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
3368
, NCT00576537
5.
Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
4 to 80
Sponsor:
Other
Protocol IDs:
09-0328
, NCT00973739
6.
Melphalan and Mannitol in Treating Patients With Central Nervous System Cancer
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 months and over
Sponsor:
NCI
Protocol IDs:
OHSU-1299
, OHSU-ONC-98018-L, OHSU-4834, NCT00253721
7.
Bone Marrow Radiation Therapy Followed by Busulfan, Melphalan, Thiotepa, and an Autologous Stem Cell Transplant in Treating Patients With High-Risk or Relapsed Solid Tumors
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Diagnostic, Treatment
Status:
Active
Age:
70 and under
Sponsor:
NCI
Protocol IDs:
UMN-2005LS023
, UMN-2005LS023, UMN-MT2004-30, NCT00623077
8.
Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Phase:
Phase I
Type:
Diagnostic, Treatment
Status:
Active
Age:
Any age
Sponsor:
Other
Protocol IDs:
4079
, NCT00671710
9.
Radiation-Induced Cytokine Cascades and Their Correlation With Central Nervous System Injury
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment
Status:
Active
Age:
All ages
Sponsor:
Other
Protocol IDs:
URCC 11095
, NCT00178295
10.
Vaccine Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
3 to 20
Sponsor:
Other
Protocol IDs:
CHP-PRO08030085
, PRO08030085, NCT00862199
11.
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Tumors
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Under 3 at diagnosis
Sponsor:
Other
Protocol IDs:
CDR0000580360
, SJCRH-SJYC07, NCT00602667
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
